| Product Code: ETC6740464 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The China contraceptive drugs and devices import market saw a significant increase in concentration in 2024, with top exporting countries being the USA, Denmark, UK, Netherlands, and Germany. The market experienced a negative Compound Annual Growth Rate (CAGR) of -0.42% from 2020 to 2024, with a steeper decline in growth rate of -6.68% from 2023 to 2024. This trend suggests a challenging landscape for the import market, potentially driven by changing consumer preferences or regulatory factors. Stakeholders should closely monitor these developments to adapt their strategies accordingly.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Contraceptive Drugs and Devices Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Contraceptive Drugs and Devices Market Revenues & Volume, 2021 & 2031F |
3.3 China Contraceptive Drugs and Devices Market - Industry Life Cycle |
3.4 China Contraceptive Drugs and Devices Market - Porter's Five Forces |
3.5 China Contraceptive Drugs and Devices Market Revenues & Volume Share, By Products, 2021 & 2031F |
3.6 China Contraceptive Drugs and Devices Market Revenues & Volume Share, By Gender, 2021 & 2031F |
4 China Contraceptive Drugs and Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about family planning and contraception methods in China |
4.2.2 Growing government initiatives to promote birth control and family planning |
4.2.3 Rising prevalence of sexually transmitted diseases (STDs) driving the demand for contraceptive drugs and devices |
4.3 Market Restraints |
4.3.1 Cultural and social taboos surrounding contraception in some regions of China |
4.3.2 Limited access to contraceptive drugs and devices in rural areas |
4.3.3 Concerns about side effects and long-term health impacts of contraceptive methods |
5 China Contraceptive Drugs and Devices Market Trends |
6 China Contraceptive Drugs and Devices Market, By Types |
6.1 China Contraceptive Drugs and Devices Market, By Products |
6.1.1 Overview and Analysis |
6.1.2 China Contraceptive Drugs and Devices Market Revenues & Volume, By Products, 2021- 2031F |
6.1.3 China Contraceptive Drugs and Devices Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.4 China Contraceptive Drugs and Devices Market Revenues & Volume, By Devices, 2021- 2031F |
6.2 China Contraceptive Drugs and Devices Market, By Gender |
6.2.1 Overview and Analysis |
6.2.2 China Contraceptive Drugs and Devices Market Revenues & Volume, By Male, 2021- 2031F |
6.2.3 China Contraceptive Drugs and Devices Market Revenues & Volume, By Female, 2021- 2031F |
7 China Contraceptive Drugs and Devices Market Import-Export Trade Statistics |
7.1 China Contraceptive Drugs and Devices Market Export to Major Countries |
7.2 China Contraceptive Drugs and Devices Market Imports from Major Countries |
8 China Contraceptive Drugs and Devices Market Key Performance Indicators |
8.1 Percentage of women in reproductive age using modern contraceptive methods |
8.2 Number of government-funded family planning programs and initiatives |
8.3 Adoption rate of long-acting reversible contraceptives (LARCs) in China |
9 China Contraceptive Drugs and Devices Market - Opportunity Assessment |
9.1 China Contraceptive Drugs and Devices Market Opportunity Assessment, By Products, 2021 & 2031F |
9.2 China Contraceptive Drugs and Devices Market Opportunity Assessment, By Gender, 2021 & 2031F |
10 China Contraceptive Drugs and Devices Market - Competitive Landscape |
10.1 China Contraceptive Drugs and Devices Market Revenue Share, By Companies, 2024 |
10.2 China Contraceptive Drugs and Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |